Welcome Message from Conference Co-Convenors
About the Cancer Research Network
Keynote Speakers
National Invited Speakers
Program
Public Lecture
NEW INSIGHTS INTO P53 PATHWAYS FUNCTION
INTERCELLULAR COMMUNICATION IN EPIDERMAL CARCINOGENESIS
EVALUATING ACCESS AND QUALITY ACROSS THE CANCER CARE CONTINUUM
PLASMA DNA-BASED GENOMIC AND METHYLOMIC PROFILING IN CANCER AND PRENATAL DIAGNOSIS: TWO SIDES OF THE SAME COIN
INFLAMMATION IN CANCER
POTENTIAL CLINICAL APPLICATIONS OF CIRCULATING TUMOUR DNA (CTDNA) IN COLORECTAL CANCER
WHEREFORE ART THOU BIOMARKER(S)?: OPPORTUNITIES FOR PROTEOMICS
STC1 EXPRESSION IS ASSOCIATED WITH TUMOUR GROWTH AND METASTASIS IN BREAST CANCER
THE C-CIRCLE ASSAY AS A BLOOD TEST FOR ALT CANCER ACTIVITY
ONCOGENIC TARGETS IN MELANOMA: WE ARE NOT DONE YET
CHALLENGES AND OPPORTUNITIES OF USING NEW TECHNOLOGIES IN CANCER MUTATION TESTING
TARGETED THERAPIES: NEW TARGETS, NEW DRUGS
TARGETING THE DNA REPLICATION CHECKPOINT BY PHARMACOLOGIC INHIBITION OF CHK1 KINASE: A STRATEGY TO SENSITIZE APC MUTANT COLON CANCER CELLS TO 5-FLUOROURACIL CHEMOTHERAPY
A NEW TARGETED THERAPY FOR THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
USING GENOMICS TO MAKE A DIFFERENCE – CAN CLINICAL AND POPULATION HEALTH PRACTICE BE CHANGED SO THAT THINGS CAN BE “DONE BETTER”?
INTEGRATION OF SUPPORTIVE CARE AND CLINICAL RESEARCH – OVERCOMING BARRIERS TO IMPLEMENTATION
REMOVING THE CANCER EMPEROR'S CLOTHES: HOW RESEARCH MOVED INTO PRACTICE WITH PLAIN TOBACCO PACKAGING
SMOKING CESSATION AFTER CANCER
HEALTH SERVICE UTILISATION AND INVESTIGATIONS BEFORE DIAGNOSIS OF CANCER OF UNKNOWN PRIMARY (CUP): A POPULATION-BASED NESTED CASE-CONTROL STUDY
TARGETED EDVTMNANOCELLS AS VERSATILE VECTORS FOR DELIVERY OF THERAPEUTICS IN CANCER: TRANSLATING A PLATFORM TECHNOLOGY INTO HUMAN CLINICAL TRIALS
PHOTOPROTECTION BY VITAMIN D COMPOUNDS
ID4 CONTROLS MAMMARY STEM CELLS AND MARKS BREAST CANCERS WITH A STEM CELL LIKE PHENOTYPE
LOSS OF VITAMIN D RECEPTOR IN BREAST CANCER CELLS ENHANCES BONE METASTASIS IN A MURINE MODEL OF BREAST CANCER
CAN ATRX DEFICIENCY BE EXPLOITED FOR ANTI-CANCER THERAPY?
APPLICATIONS OF MONOCLONAL ANTIBODIES TO DENDRITIC CELLS FOR THE DIAGNOSIS AND TREATMENT OF HAEMATOLOGICAL AND OTHER MALIGNANCIES
CELL AND GENE THERAPY UPDATE
CANCER IMMUNOTHERAPY – HOLY GRAIL OR PANDORA'S BOX?
A SAFETY STUDY TREATING CANINE CANCER PATIENTS WITH AUTOLOGOUS VACCINES
THE ETS TRANSCRIPTION FACTOR ELF5 IS A KEY DETERMINANT OF THE LETHAL PHENOTYPE IN LUMINAL BREAST CANCER, DRIVING THE ACQUISITION OF ANTIESTROGEN RESISTANCE AND METASTATIC ACTIVITY
DERIVING CANCER-SPECIFIC UTILITY WEIGHTS FROM THE QLQ-C30: A DISCRETE CHOICE METHODS EXPERIMENT
AUSTRALIAN IMPLEMENTATION OF SCALP COOLING FOR PREVENTION OF CHEMOTHERAPY INDUCED ALOPECIA
COGNITION AFTER CHEMOTHERAPY: AN OVERVIEW
A NEW CONCEPTUAL FRAMEWORK AND CLINICAL STRATEGIES TO MANAGE AND ENHANCE FAMILY INVOLVEMENT IN CANCER CONSULTATIONS
WHAT'S IN A NAME: HOW DIFFERENT TERMINOLOGY IMPACTS COMMUNITY CONCERN AND TREATMENT PREFERENCES FOR DCIS
BIG DATA LINKAGES: THE MAGIC BULLET FOR CANCER HEALTH SERVICE RESEARCH?
WHOLE GENOME METHYLATION SEQUENCING IDENTIFIES POTENTIAL EPIGENETIC- BASED CANCER BIOMARKERS
MICROTUBULE TARGETS IN CANCER: POTENTIAL OF NANOTECHNOLOGY-BASED THERAPEUTICS
CANCER PROGRESSION AND RECURRENCE: WHAT WE CAN LEARN FROM EVOLUTIONARY BIOLOGY
EXPLOITING HSA TO STIMULATE THE DELIVERY AND ANTI-TUMOUR ACTIVITY OF THE ANTI-CANCER THIOSEMICARBAZONE, DP44MT, TO CANCER CELLS
METASTASIS SUPPRESSOR, N-MYC DOWNSTREAM REGULATED GENE 1 (NDRG1), INHIBITS PRO-SURVIVAL AUTOPHAGIC PATHWAY IN CANCER CELLS
NON-MUTATED PROTEINS AS TARGETS FOR CANCER THERAPY
DETERMINING THE EFFECTIVENESS OF TARGETED THERAPIES: CHALLENGES, STRATEGIES AND PITFALLS
USING PATIENT-DERIVED XENOGRAFTS TO DEFINE ACTIONABLE ABERRATIONS IN HIGH-GRADE SEROUS CANCER
RESTORING EXPRESSION OF MIR-7 BY TARGETED BACTERIAL MINICELLS INHIBITS THE MAPK/ERK PATHWAY AND OFFERS A NOVEL THERAPY FOR ADRENOCORTICAL CANCER
TUMOUR SUPPRESSOR FUNCTIONS OF MIR-192 AND MIR-193A-3P IN MALIGNANT PLEURAL MESOTHELIOMA
THE PROMPT-CARE PROJECT: EHEALTH SYSTEM UTILISING PATIENT REPORTED OUTCOMES TO INFORM PERSONALISED CANCER TREATMENT AND CARE
A SYSTEMATIC APPROACH TO CLOSING EVIDENCE GAPS IN CANCER CARE
LUNG CANCER REFERRAL INTERVAL TIMES: A MIXED METHODS STUDY
AN INTERNATIONAL SURVEY OF AWARENESS OF GENETIC RISK IN THE CLINICAL SARCOMA COMMUNITY
USING A MULTI- DISCIPLINARY PROGRAM OF CANCER CARE AS A VEHICLE FOR MORE EFFECTIVE RESEARCH TRANSLATION
TISSUE ENGINEERED HUMANIZED BONE SUPPORTS HUMAN HEMATOPOIESIS IN VIVO
NOVEL ANTIBODY SCAFFOLDS FOR THERAPY OF SOLID TUMOURS
APPLICATIONS OF PATIENT-DERIVED SUBRENAL CAPSULE TUMOUR XENOGRAFT MODELS IN MICE
QUANTITATIVE BIOLOGICALLY GUIDED CANCER TREATMENT USING MULTI-NUCLEAR MAGNETIC RESONANCE IMAGING
DISTINCTIVE WATER DIFFUSION PROPERTIES OF EPITHELIA MAY BE THE KEY TO BETTER CANCER IMAGING TECHNIQUES
OESOPHAGEAL ADENOCARCINOMA GENOMICS
KNOW THY ENEMY: USING GENOMICS TO UNDERSTAND MOLECULAR SUB-TYPES OF EPITHELIAL OVARIAN CANCER
TARGETED THERAPY RESISTANCE AND IMPLICATIONS FOR PERSONALISED THERAPY IN MELANOMA
A NEW BETA-CATENIN REGULATORY PATHWAY AS A POTENTIAL TREATMENT TARGET IN COLON CANCER
POTENTIAL DRIVER GENES OF OVARIAN CARCINOGENESIS IDENTIFIED BY SLEEPING BEAUTY MUTAGENESIS
TRANSLATING EPIDEMIOLOGICAL RESEARCH IN GYNAECOLOGICAL CANCER INTO CANCER CONTROL
SURVIVORSHIP CARE FOR PEOPLE WITH COLORECTAL CANCER: A POPULATION-BASED SURVEY OF PATIENTS' EXPERIENCES AND PREFERENCES
IMPACT OF COMMON GENOMIC VARIANTS ON MELANOMA RISK PREDICTION
INFORMING WOMEN ABOUT OVERDETECTION OF BREAST CANCER: RANDOMISED TRIAL OF A MAMMOGRAPHY SCREENING DECISION AID
WHY ARE TWO IN FIVE PROSTATE CANCER CASES RECORDED AS HAVING “UNKNOWN” STAGE OF DISEASE IN AN AUSTRALIAN POPULATION-BASED CANCER REGISTRY? A STUDY OF HEALTH SERVICE FACTORS
SYNTHESIS AND CHARACTERISATION OF STERICALLY HINDERED PYRIDINE BASED MULTINUCLEAR PLATINUM ANTICANCER COMPLEXES AND THEIR CYTOTOXICITY
SYNERGISM FROM SEQUENCED COMBINATIONS OF GENISTEIN, CURCUMIN, RESVERATROL, QUERCEITIN AND CAPSAICIN WITH DESIGNED MONOFUNCTIONAL PLATINUMS IN THE KILLING OF HUMAN OVARIAN CANCER CELLS
MINOCYCLINE REGULATES HYPOXIA-INDUCIBLE FACTOR-1Î ± EXPRESSION THROUGH THE INDUCTION OF ITS DEGRADATION IN OVARIAN CANCER: IN VITRO AND IN VIVO STUDIES
A NOVEL AMINOACETONITRILE DERIVATIVE, MONEPANTEL (AAD-1566) INHIBITS OVARIAN CANCER CELL GROWTH THROUGH SUPPRESSION MTORC1 AND INDUCTION OF AUTOPHAGY
STUDIES ON COMBINATIONS OF TARGETED DRUGS WITH TUMOUR ACTIVE PLANT COMPOUNDS IN CANCER
DEVELOPMENT AND TESTING THE ACCEPTABILITY OF REKINDLE, A WEB-BASED PSYCHOSEXUAL RESOURCE FOR ALL CANCER SURVIVORS AND THEIR PARTNERS
MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR: A POTENTIAL CELL SURFACE MARKER FOR PROSTATE ONCOGENESIS
COPPER AND CHEMOTHERAPY TRANSPORTER CTR1, INFLUENCES EMBRYONIC AND TUMOUR DEVELOPMENT
DIFFERENCE IN CHROMATIN STRUCTURE BETWEEN ALT AND TELOMERASE CANCER CELLS
MONEPANTEL (AAD556) INDUCES AUTOPHAGY IN HUMAN GLIOBLASTOMA CELLS
CHARACTERISATION OF A NOVEL TRUNCATED FORM OF CALCIUM-BINDING PROTEIN S100P AND ITS POTENTIAL ROLE AS A PROGNOSTIC MARKER IN BREAST CANCER
DO CANCER PATIENTS DISTINGUISH BETWEEN THE IMPORTANCE AND SEVERITY OF THEIR QUALITY OF LIFE CONCERNS?
THE DEVELOPMENT OF CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENTS FROM THE EORTC QLQ-C30 AND FACT-G
SAFEGUARDING RADIOTHERAPY CANCER TREATMENT: MEASURING RADIATION DOSE IN THREE DIMENSIONS
STEM CELL APPROACH TO GENERATE MULTIPLE IMMUNE EFFECTOR CELLS TO TREAT CANCER
BRAF V600E MUTATION STATUS AND ASSOCIATED HISTOPATHOLOGY FEATURES IN PAPILLARY THYROID CARCINOMA: A COMPARISON OF NEW CALEDONIA AND AUSTRALIAN POPULATIONS
P17 DEVELOPMENT OF AN INTERVENTION FOR COMMUNICATING PERSONAL GENETIC RISK OF MELANOMA TO THE GENERAL PUBLIC
EPITHELIAL CELL MOVEMENT AND NUCLEAR AND CYTOPLASMIC FORMS OF THE ESSENTIAL PROTEASE DIPEPTIDYL PEPTIDASE 9 (DPP9)
VITAMIN D3 (CHOLECALCIFEROL) ACTS AS A NEGATIVE REGULATOR OF BREAST CANCER CELL INVASIVENESS IN THE ABSENCE OF ACTIVATION OF CLASSICAL VDR SIGNALLING
GOAL PROCESSES, COPING, AND ADJUSTMENT IN YOUNG ADULTS WITH TESTICULAR CANCER
DRY EYES & AIS
RAC1 ACTIVATION CAUSES A REDISTRIBUTION OF β-CATENIN-RAC1 COMPLEXES FROM MEMBRANE TO NUCLEUS: A NEW MODEL FOR RAC1 STIMULATION OF WNT SIGNALLING IN CANCER
THE ROLE OF MDTS IN SUPPORTING RESEARCH TRANSLATION
A RARE CASE OF CUTANEOUS MULTIPLE MYELOMA
TARGETED TREATMENT OF LUNG CANCER USING SILK-BASED DRUG CARRIERS
CLOSING THE GAP BETWEEN RESEARCH, BIOBANKS AND CLINICAL PRACTICE: A 12 MONTH EXPLORATORY STUDY INTO DEVELOPING A STANDARD PRE-OPERATIVE MODEL FOR OBTAINING BIOBANK CONSENT
SYNTHESIS AND IN-VITRO EVALUATION OF ANTICANCER RH(III) COMPLEXES
THE SYNTHESIS AND BIOLOGICAL STUDY CURCUMIN ANALOGUES AS ANTICANCER AGENTS
ROLE OF FOCAL ADHESION KINASE IN GLIOMA STEM CELLS
INCREASING PREVALENCE EXPECTATION IN THORACIC RADIOLOGY LEADS TO OVERCALL
THE CHARACTERISATION OF APC LOCALISATION, DYNAMICS AND FUNCTION AT THE CENTROSOME
ACCURACY OF ULTRASOUND DURING NEOADJUVANT THERAPY FOR BREAST CANCER TO PREDICT PATHOLOGIC RESPONSE
DEFINING A MOLECULAR “SWITCH” IN COLON CANCER: REGULATION OF THE BETA-CATENIN DEGRADATION COMPLEX
THE ROLE OF SPECIFIC BARD1 SPLICE VARIANT ISOFORMS IN BREAST CANCER CELL RESISTANCE TO DNA DAMAGING AGENTS
THE METASTASIS SUPPRESSOR NDRG1 DOWN-REGULATES THE EXPRESSION OF SNAIL AND SLUG TO PROMOTE E-CADHERIN EXPRESSION IN PANCREATIC CANCER
MODE OF ADMINISTRATION OF PATIENT-REPORTED OUTCOMES (PRO) MEASURES: A SYSTEMATIC REVIEW
INVESTIGATION OF THE GENETIC PREDISPOSITION TO CANINE LYMPHOMA
3D TISSUE CULTURE- A MORE EFFICIENT AND PREDICTIVE MODEL FOR THE ASSESSMENT OF EDVTMNANOCELL DELIVERY TO TUMOURS
LEGITIMACY OF FUNDING DECISIONS FOR CANCER MEDICINES: A THEMATIC ANALYSIS OF STAKEHOLDER PERSPECTIVES
COSTS OF CANCER CARE AT THE END OF LIFE
RESOURCE USE IN THE LAST 180 DAYS OF LIFE IN THE ELDERLY DECENDENTS
A CANCER RISK-ASSOCIATED POLYMORPHISM IN THE TERT LOCUS ENCODES A NOVEL SPLICE VARIANT WHICH IS A DOMINANT NEGATIVE INHIBITOR OF TELOMERASE
IMPLEMENTING A CLINICAL PATHWAY FOR CANCER ANXIETY, DEPRESSION AND DISTRESS: WHAT DOES A QUALITATIVE ANALYSIS TELL US ABOUT BARRIERS AND ENABLERS?
STRUCTURAL FEATURES OF BROAD-SPECTRUM ANTI-CANCER BAMLET COMPOUNDS
THE IMPACT OF DUCTAL CARCINOMA IN SITU (DCIS) OF THE BREAST ON PATIENT-REPORTED OUTCOMES (PROS): A SYSTEMATIC REVIEW
THE ROLE OF TRANSITION METALS IN PROTEIN PHOSPHORYLATION IN HUMAN HEALTH AND DISEASES
ANTITUMOUR ACTIVITY OF WEDELOLACTONE, BETULINIC ACID AND EPIGALLOCATECHIN-3-GALLATE (EGCG) IN OVARIAN CANCER CELL LINES
OBESITY-RELATED BREAST TUMORIGENESIS IN RESPONSE TO A HIGH-FAT DIET IS RELATED TO INCREASED MAMMARY FAT PAD MASS
INVESTIGATING THE ROLE OF LONG NON-CODING RNAS IN CISPLATIN RESISTANCE IN OVARIAN CANCER
SOCIOECONOMIC DISPARITIES IN SURVIVAL OVER TIME FOR 10 MAJOR CANCERS IN NEW SOUTH WALES, AUSTRALIA: 1996–2008
Anthropogenic selection enhances cancer evolution in Tasmanian devil tumours
TARGETED DELIVERY OF PLATINUM DRUGS TO TUMOURS USING CARRIER DNA-TETHERED APTAMERS
THYROID FNA BRAF POSITIVITY CORRELATES WITH A HIGHER GRADE BETHESDA CATEGORY
INTEGRATIVE ANALYSIS OF MRNA EXPRESSION PROFILES IDENTIFIES NOVEL TARGETS FOR THERAPY IN MALIGNANT PLEURAL MESOTHELIOMA (MPM)
DIPEPTIDYL PEPTIDASE 9 HAS ROLES IN CELL ADHESION AND MIGRATION OF HEPATOMA CELLS
ENDOCYTOSIS IN MITOSIS: THE ROLE OF SNX9 IN CYTOKINESIS
TEN YEAR REVIEW OF THE WAIKATO EXPERIENCE OF MICROCYSTIC ADNEXAL CARCINOMA: A RARE BUT SIGNFICANT HEAD AND NECK TUMOUR
DELETERIOUS PASSENGER MUTATIONS AS A BIOMARKER FOR HEPATOCELLULAR CARCINOMA
THE P38-MK2-HUR PATHWAY POTENTIATES EGFRVIII-IL-1β-DRIVEN IL-6 SECRETION IN GLIOBLASTOMA CELLS
INTRODUCING DRUG DELIVERY VEHICLE IN ALBENDAZOLE DECREASES TUMOR BURDEN, REDUCES VEGF AND INHIBITS ASCITES IN OVARIAN CANCER XENOGRAFT MODEL
Sponsors and Exhibitors
General Information
Conference Venue